We studied whether microalbuminuria (urinary albumin excretion rates of 15 to 150 micrograms per minute) would predict the development of increased proteinuria in Type I diabetes. We also studied the influence of glomerular filtration rate, renal blood flow, and blood pressure on the later development of proteinuria. Forty-four patients who had had Type I diabetes for at least seven years and who had albumin excretion rates below 150 micrograms per minute were studied from 1969 to 1976, and 43 were restudied in 1983. Of the 14 who initially had albumin excretion rates at or above 15 micrograms per minute, 12 had clinically detectable proteinuria (over 500 mg of protein per 24 hours) or an albumin excretion rate above 150 micrograms per minute at the later examination. Of the 29 who initially had albumin excretion rates below 15 micrograms per minute, none had clinically detectable proteinuria at the later examination, although four had microalbuminuria. Those whose condition progressed to clinically overt proteinuria had elevated glomerular filtration rates and higher blood pressures at the initial examination than did those in whom proteinuria did not develop. Renal blood flow was not elevated in these patients. We conclude that microalbuminuria predicts the development of diabetic nephropathy and that elevated glomerular filtration rates and increased blood pressure may also contribute to this progression.
This article has been cited by other articles:
Uehara, Y., Makino, H., Seiki, K., Urade, Y., on behalf of L-PGDS Clinical Research Group of Kid,
(2008). Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study. Nephrol Dial Transplant
0: gfn515v1-gfn515
[Abstract][Full Text]
Rademacher, E., Mauer, M., Jacobs, D. R. Jr, Chavers, B., Steinke, J., Sinaiko, A.
(2008). Albumin Excretion Rate in Normal Adolescents: Relation to Insulin Resistance and Cardiovascular Risk Factors and Comparisons to Type 1 Diabetes Mellitus Patients. CJASN
3: 998-1005
[Abstract][Full Text]
Nguyen, S., McCulloch, C., Brakeman, P., Portale, A., Hsu, C.-y.
(2008). Being Overweight Modifies the Association Between Cardiovascular Risk Factors and Microalbuminuria in Adolescents. Pediatrics
121: 37-45
[Abstract][Full Text]
Inrig, J. K., Gillespie, B. S., Patel, U. D., Briley, L. P., She, L., Easton, J. D., Topol, E., Szczech, L. A.
(2007). Risk for Cardiovascular Outcomes among Subjects with Atherosclerotic Cardiovascular Disease and Greater-than-Normal Estimated Glomerular Filtration Rate. CJASN
2: 1215-1222
[Abstract][Full Text]
Metcalfe, W.
(2007). How does early chronic kidney disease progress?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease. Nephrol Dial Transplant
22: ix26-ix30
[Full Text]
Wong, D. W., Oudit, G. Y., Reich, H., Kassiri, Z., Zhou, J., Liu, Q. C., Backx, P. H., Penninger, J. M., Herzenberg, A. M., Scholey, J. W.
(2007). Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury. Am. J. Pathol.
171: 438-451
[Abstract][Full Text]
Ficociello, L. H., Perkins, B. A., Silva, K. H., Finkelstein, D. M., Ignatowska-Switalska, H., Gaciong, Z., Cupples, L. A., Aschengrau, A., Warram, J. H., Krolewski, A. S.
(2007). Determinants of Progression from Microalbuminuria to Proteinuria in Patients Who Have Type 1 Diabetes and Are Treated with Angiotensin-Converting Enzyme Inhibitors. CJASN
2: 461-469
[Abstract][Full Text]
Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., Krolewski, A. S.
(2007). Microalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes. J. Am. Soc. Nephrol.
18: 1353-1361
[Abstract][Full Text]
Aaltonen, P., Rinta-Valkama, J., Patari, A., Tossavainen, P., Palmen, T., Kulmala, P., Knip, M., Holthofer, H.
(2007). Circulating antibodies to nephrin in patients with type 1 diabetes. Nephrol Dial Transplant
22: 146-153
[Abstract][Full Text]
Chan, O. T.M., Herold, D. A.
(2006). Chip Electrophoresis as a Method for Quantifying Total Microalbuminuria. Clin. Chem.
52: 2141-2146
[Abstract][Full Text]
Zerbini, G., Bonfanti, R., Meschi, F., Bognetti, E., Paesano, P. L., Gianolli, L., Querques, M., Maestroni, A., Calori, G., Del Maschio, A., Fazio, F., Luzi, L., Chiumello, G.
(2006). Persistent Renal Hypertrophy and Faster Decline of Glomerular Filtration Rate Precede the Development of Microalbuminuria in Type 1 Diabetes. Diabetes
55: 2620-2625
[Abstract][Full Text]
de Jong, P. E., Curhan, G. C.
(2006). Screening, Monitoring, and Treatment of Albuminuria: Public Health Perspectives. J. Am. Soc. Nephrol.
17: 2120-2126
[Abstract][Full Text]
Gansevoort, R. T., Bakker, S. J.L., de Jong, P. E.
(2006). Early Detection of Progressive Chronic Kidney Disease: Is It Feasible?. J. Am. Soc. Nephrol.
17: 1218-1220
[Full Text]
Svensson, M., Nystrom, L., Schon, S., Dahlquist, G., on behalf of the Swedish Childhood Diabetes Study,
(2006). Age at Onset of Childhood-Onset Type 1 Diabetes and the Development of End-Stage Renal Disease: A nationwide population-based study.. Diabetes Care
29: 538-542
[Abstract][Full Text]
Caramori, M. L., Fioretto, P., Mauer, M.
(2006). Enhancing the Predictive Value of Urinary Albumin for Diabetic Nephropathy. J. Am. Soc. Nephrol.
17: 339-352
[Abstract][Full Text]
Sedor, J. R.
(2006). Frontiers in Diabetic Nephropathy: Can We Predict Who Will Get Sick?. J. Am. Soc. Nephrol.
17: 336-338
[Full Text]
Incerti, J., Zelmanovitz, T., Camargo, J. L., Gross, J. L., de Azevedo, M. J.
(2005). Evaluation of tests for microalbuminuria screening in patients with diabetes. Nephrol Dial Transplant
20: 2402-2407
[Abstract][Full Text]
Brinkman, J. W., de Zeeuw, D., Duker, J. J., Gansevoort, R. T., Kema, I. P., Hillege, H. L., de Jong, P. E., Bakker, S. J.L.
(2005). Falsely Low Urinary Albumin Concentrations after Prolonged Frozen Storage of Urine Samples. Clin. Chem.
51: 2181-2183
[Full Text]
Leitao, C. B., Canani, L. H., Bolson, P. B., Molon, M. P., Pinotti, A. F., Gross, J. L.
(2005). Urinary Albumin Excretion Rate Is Associated With Increased Ambulatory Blood Pressure in Normoalbuminuric Type 2 Diabetic Patients. Diabetes Care
28: 1724-1729
[Abstract][Full Text]
Steinke, J. M., Sinaiko, A. R., Kramer, M. S., Suissa, S., Chavers, B. M., Mauer, M., for the International Diabetic Nephropathy Study G,
(2005). The Early Natural History of Nephropathy in Type 1 Diabetes: III. Predictors of 5-Year Urinary Albumin Excretion Rate Patterns in Initially Normoalbuminuric Patients. Diabetes
54: 2164-2171
[Abstract][Full Text]
Baskar, V., Kamalakannan, D., Kiberd, B., Holland, M.R., Singh, B.M.
(2005). Hypertension-based clinical risk strategies for detecting microalbuminuria in diabetes. QJM
98: 427-433
[Abstract][Full Text]
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., Zelmanovitz, T.
(2005). Diabetic Nephropathy: Diagnosis, Prevention, and Treatment. Diabetes Care
28: 164-176
[Abstract][Full Text]
Samnegard, B., Jacobson, S. H., Johansson, B.-L., Ekberg, K., Isaksson, B., Wahren, J., Sjoquist, M.
(2004). C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant
19: 1385-1391
[Abstract][Full Text]
Choi, S., Choi, E. Y., Kim, H. S., Oh, S. W.
(2004). On-Site Quantification of Human Urinary Albumin by a Fluorescence Immunoassay. Clin. Chem.
50: 1052-1055
[Full Text]
Svensson, M., Eriksson, J. W., Dahlquist, G.
(2004). Early Glycemic Control, Age at Onset, and Development of Microvascular Complications in Childhood-Onset Type 1 Diabetes: A population-based study in northern Sweden. Diabetes Care
27: 955-962
[Abstract][Full Text]
Lane, J. T.
(2004). Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective. Am. J. Physiol. Renal Physiol.
286: F442-F450
[Abstract][Full Text]
Luippold, G., Beilharz, M., Muhlbauer, B.
(2004). Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant
19: 342-347
[Abstract][Full Text]
Murtaugh, M. A., Jacobs, D. R. Jr., Yu, X., Gross, M. D., Steffes, M.
(2003). Correlates of Urinary Albumin Excretion in Young Adult Blacks and Whites: The Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol
158: 676-686
[Abstract][Full Text]
Allen, K. V., Walker, J. D.
(2003). Microalbuminuria and Mortality in Long-Duration Type 1 Diabetes. Diabetes Care
26: 2389-2391
[Abstract][Full Text]
Arun, C. S., Stoddart, J., Mackin, P., MacLeod, J. M., New, J. P., Marshall, S. M.
(2003). Significance of Microalbuminuria in Long-Duration Type 1 Diabetes. Diabetes Care
26: 2144-2149
[Abstract][Full Text]
Kramer, H. J., Nguyen, Q. D., Curhan, G., Hsu, C.-y.
(2003). Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults With Type 2 Diabetes Mellitus. JAMA
289: 3273-3277
[Abstract][Full Text]
Yu, H. T.
(2003). Progression of Chronic Renal Failure. Arch Intern Med
163: 1417-1429
[Abstract][Full Text]
Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., Krolewski, A. S.
(2003). Regression of Microalbuminuria in Type 1 Diabetes. NEJM
348: 2285-2293
[Abstract][Full Text]
Poulsen, L.
(2003). Review: Early renal involvement in Type 1 diabetes mellitus -- Part 2: ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria. Journal of Renin-Angiotensin-Aldosterone System
4: 17-26
[Abstract]
Yano, Y., Kitagawa, N., Gabazza, E. C., Morioka, K., Urakawa, H., Tanaka, T., Katsuki, A., Araki-Sasaki, R., Hori, Y., Nakatani, K., Taguchi, O., Sumida, Y., Adachi, Y.
(2003). Increased Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels in Normotensive Type 2 Diabetic Patients with Microalbuminuria. J. Clin. Endocrinol. Metab.
88: 736-741
[Abstract][Full Text]
Ruggenenti, P., Flores, C., Aros, C., Ene-Iordache, B., Trevisan, R., Ottomano, C., Remuzzi, G.
(2003). Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy. Diabetes Care
26: 502-509
[Abstract][Full Text]
Vallon, V., Blantz, R. C., Thomson, S.
(2003). Glomerular Hyperfiltration and the Salt Paradox in Early Type 1 Diabetes Mellitus: A Tubulo-Centric View. J. Am. Soc. Nephrol.
14: 530-537
[Abstract][Full Text]
Poulsen, L.
(2002). Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes. Journal of Renin-Angiotensin-Aldosterone System
3: 222-242
[Abstract]
Huang, C., Kim, Y., Caramori, M. L. A., Fish, A. J., Rich, S. S., Miller, M. E., Russell, G. B., Mauer, M.
(2002). Cellular Basis of Diabetic Nephropathy: II. The Transforming Growth Factor-{beta} System and Diabetic Nephropathy Lesions in Type 1 Diabetes. Diabetes
51: 3577-3581
[Abstract][Full Text]
Thirone, A. C.P., Scarlett, J. A., Gasparetti, A. L., Araujo, E. P., Lima, M. H.L., Carvalho, C. R.O., Velloso, L. A., Saad, M. J.A.
(2002). Modulation of Growth Hormone Signal Transduction in Kidneys of Streptozotocin-Induced Diabetic Animals: Effect of a Growth Hormone Receptor Antagonist. Diabetes
51: 2270-2281
[Abstract][Full Text]
Vallon, V., Huang, D.-Y., Deng, A., Richter, K., Blantz, R. C., Thomson, S.
(2002). Salt-Sensitivity of Proximal Reabsorption Alters Macula Densa Salt and Explains the Paradoxical Effect of Dietary Salt on Glomerular Filtration Rate in Diabetes Mellitus. J. Am. Soc. Nephrol.
13: 1865-1871
[Abstract][Full Text]
Hoehner, C. M., Greenlund, K. J., Rith-Najarian, S., Casper, M. L., McClellan, W. M.
(2002). Association of the Insulin Resistance Syndrome and Microalbuminuria among Nondiabetic Native Americans.The Inter-Tribal Heart Project. J. Am. Soc. Nephrol.
13: 1626-1634
[Abstract][Full Text]
Rossing, P., Hougaard, P., Parving, H.-H.
(2002). Risk Factors for Development of Incipient and Overt Diabetic Nephropathy in Type 1 Diabetic Patients: A 10-year prospective observational study. Diabetes Care
25: 859-864
[Abstract][Full Text]
Ueno, Y., Kizaki, M., Nakagiri, R., Kamiya, T., Sumi, H., Osawa, T.
(2002). Dietary Glutathione Protects Rats from Diabetic Nephropathy and Neuropathy. J. Nutr.
132: 897-900
[Abstract][Full Text]
Abid, O., Sun, Q., Sugimoto, K., Mercan, D., Vincent, J.-L.
(2001). Predictive Value of Microalbuminuria in Medical ICU Patients : Results of a Pilot Study. Chest
120: 1984-1988
[Abstract][Full Text]
Go, R. C.P., Desmond, R., Roseman, J. M., Bell, D. S.H., Vanichanan, C., Acton, R. T.
(2001). Prevalence and Risk Factors of Microalbuminuria in a Cohort of African-American Women With Gestational Diabetes. Diabetes Care
24: 1764-1769
[Abstract][Full Text]
Tabaei, B. P., Al-Kassab, A. S., Ilag, L. L., Zawacki, C. M., Herman, W. H.
(2001). Does Microalbuminuria Predict Diabetic Nephropathy?. Diabetes Care
24: 1560-1566
[Abstract][Full Text]
Luippold, G., Beilharz, M., Muhlbauer, B.
(2001). Reduction of glomerular hyperfiltration by dopamine D2-like receptor blockade in experimental diabetes mellitus. Nephrol Dial Transplant
16: 1350-1356
[Abstract][Full Text]
Dahlquist, G., Stattin, E.-L., Rudberg, S.
(2001). Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients. Nephrol Dial Transplant
16: 1382-1386
[Abstract][Full Text]
Nannipieri, M., Manganiello, M., Pezzatini, A., De Bellis, A., Seghieri, G., Ferrannini, E.
(2001). Polymorphisms in the hANP (Human Atrial Natriuretic Peptide) Gene, Albuminuria, and Hypertension. Hypertension
37: 1416-1422
[Abstract][Full Text]
Cohen, C. N., Albanesi, F. M., Gonçalves, M. F., Gomes, M. B.
(2001). Microalbuminuria, High Blood Pressure Burden, and Nondipper Phenomenon: An interaction in normotensive type 1 diabetic patients. Diabetes Care
24: 790-791
[Full Text]
Nejsum, L. N., Kwon, T.-H., Marples, D., Flyvbjerg, A., Knepper, M. A., Frokiar, J., Nielsen, S.
(2001). Compensatory increase in AQP2, p-AQP2, and AQP3 expression in rats with diabetes mellitus. Am. J. Physiol. Renal Physiol.
280: F715-F726
[Abstract][Full Text]
Schultz, C. J., Neil, H. A. W., Dalton, R. N., Bahu, T. K., Dunger, D. B.
(2001). Blood Pressure Does Not Rise Before the Onset of Microalbuminuria in Children Followed From Diagnosis of Type 1 Diabetes. Diabetes Care
24: 555-560
[Abstract][Full Text]
LEMLEY, K. V., BLOUCH, K., ABDULLAH, I., BOOTHROYD, D. B., BENNETT, P. H., MYERS, B. D., NELSON, R. G.
(2000). Glomerular Permselectivity at the Onset of Nephropathy in Type 2 Diabetes Mellitus. J. Am. Soc. Nephrol.
11: 2095-2105
[Abstract][Full Text]
Mogensen, C. E.
(2000). ACE inhibitors and antihypertensive treatment in diabetes: focus on microalbuminuria and macrovascular disease. Journal of Renin-Angiotensin-Aldosterone System
1: 234-239
Moore, T H M, Shield, J P H
(2000). Prevalence of abnormal urinary albumin excretion in adolescents and children with insulin dependent diabetes: the MIDAC study. Arch. Dis. Child.
83: 239-243
[Abstract][Full Text]
Hsieh, M.-C., Lin, S.-R., Hsieh, T.-J., Hsu, C.-H., Chen, H.-C., Shin, S.-J., Tsai, J.-H.
(2000). Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant
15: 1008-1013
[Abstract][Full Text]
Hill, C., Flyvbjerg, A., Gronbak, H., Petrik, J., Hill, D. J., Thomas, C. R., Sheppard, M. C., Logan, A.
(2000). The Renal Expression of Transforming Growth Factor-{beta} Isoforms and Their Receptors in Acute and Chronic Experimental Diabetes in Rats. Endocrinology
141: 1196-1208
[Abstract][Full Text]
Kotchen, T. A., Piering, A. W., Cowley, A. W., Grim, C. E., Gaudet, D., Hamet, P., Kaldunski, M. L., Kotchen, J. M., Roman, R. J.
(2000). Glomerular Hyperfiltration in Hypertensive African Americans. Hypertension
35: 822-826
[Abstract][Full Text]
Feldman, R. D., Campbell, N., Larochelle, P., Bolli, P., Burgess, E. D., Carruthers, S. G., Floras, J. S., Haynes, R. B., Honos, G., Leenen, F. H.H., Leiter, L. A., Logan, A. G., Myers, M. G., Spence, J. D., Zarnke, K. B.
(1999). 1999 Canadian recommendations for the management of hypertension. CMAJ
161: S1-17
[Abstract][Full Text]
VALLON, V., RICHTER, K., BLANTZ, R. C., THOMSON, S., OSSWALD, H.
(1999). Glomerular Hyperfiltration in Experimental Diabetes Mellitus: Potential Role of Tubular Reabsorption. J. Am. Soc. Nephrol.
10: 2569-2576
[Abstract][Full Text]
Yano, Y., Katsuki, A., Gabazza, E. C., Ito, K., Fujii, M., Furuta, M., Tuchihashi, K., Goto, H., Nakatani, K., Hori, Y., Sumida, Y., Adachi, Y.
(1999). Plasma Brain Natriuretic Peptide Levels in Normotensive Noninsulin-Dependent Diabetic Patients with Microalbuminuria. J. Clin. Endocrinol. Metab.
84: 2353-2356
[Abstract][Full Text]
Sung, B. H., Izzo, J. L. Jr, Dandona, P., Wilson, M. F.
(1999). Vasodilatory Effects of Troglitazone Improve Blood Pressure at Rest and During Mental Stress in Type 2 Diabetes Mellitus. Hypertension
34: 83-88
[Abstract][Full Text]
Parsons, M. P., Newman, D. J., Newall, R. G., Price, C. P.
(1999). Validation of a Point-of-Care Assay for the Urinary Albumin:Creatinine Ratio. Clin. Chem.
45: 414-417
[Full Text]
Marre, M., Bouhanick, B., Berrut, G., Gallois, Y., Le Jeune, J.-J., Chatellier, G., Menard, J., Alhenc-Gelas, F.
(1999). Renal Changes on Hyperglycemia and Angiotensin-Converting Enzyme in Type 1 Diabetes. Hypertension
33: 775-780
[Abstract][Full Text]
Bouhanick, B., Hadjadj, S., Marre, M.
(1999). Microalbuminuria, glomerular filtration rate, and dietary fat and protein intakes in type 1 diabetes. Am. J. Clin. Nutr.
69: 153-153
[Full Text]
Cirillo, M., Senigalliesi, L., Laurenzi, M., Alfieri, R., Stamler, J., Stamler, R., Panarelli, W., De Santo, N. G.
(1998). Microalbuminuria in Nondiabetic Adults: Relation of Blood Pressure, Body Mass Index, Plasma Cholesterol Levels, and Smoking: The Gubbio Population Study. Arch Intern Med
158: 1933-1939
[Abstract][Full Text]
Vallon, V., Albinus, M., Blach, D.
(1998). Effect of KATP Channel Blocker U37883A on Renal Function in Experimental Diabetes Mellitus in Rats. J. Pharmacol. Exp. Ther.
286: 1215-1221
[Abstract][Full Text]
Jones, C A, Leese, G P, Kerr, S, Bestwick, K, Isherwood, D I, Vora, J P, Hughes, D A, Smith, C
(1998). Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus. Arch. Dis. Child.
78: 518-523
[Abstract][Full Text]
Ellis, D., Forrest, K. Y-Z, Erbey, J., Orchard, T. J.
(1998). Urinary measurement of transforming growth factor-{beta} and type IV collagen as new markers of renal injury: application in diabetic nephropathy. Clin. Chem.
44: 950-956
[Abstract][Full Text]
Kessler, M. A., Meinitzer, A., Petek, W., Wolfbeis, O. S.
(1997). Microalbuminuria and borderline-increased albumin excretion determined with a centrifugal analyzer and the Albumin Blue 580 fluorescence assay. Clin. Chem.
43: 996-1002
[Abstract][Full Text]
Thakkar, H., Newman, D. J., Holownia, P., Davey, C. L., Wang, C.-C., Lloyd, J., Craig, A. R., Price, C. P.
(1997). Development and validation of a particle-enhanced turbidimetric inhibition assay for urine albumin on the Dade aca(R) analyzer. Clin. Chem.
43: 109-113
[Abstract][Full Text]
Rossing, P., Hougaard, P., Borch-Johnsen, K., Parving, H.-H.
(1996). Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ
313: 779-784
[Abstract][Full Text]
Jyothirmayi, G. N., Alluru, I., Reddi, A. S.
(1996). Doxazosin Prevents Proteinuria and Glomerular Loss of Heparan Sulfate in Diabetic Rats. Hypertension
27: 1108-1114
[Abstract][Full Text]
Doria, A., Onuma, T., Gearin, G., Freire, M. B. S., Warram, J. H., Krolewski, A. S.
(1996). Angiotensinogen Polymorphism M235T, Hypertension, and Nephropathy in Insulin-Dependent Diabetes. Hypertension
27: 1134-1139
[Abstract][Full Text]
Kario, K., Matsuo, T., Kobayashi, H., Matsuo, M., Sakata, T., Miyata, T.
(1995). Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With Microalbuminuria. Arterioscler. Thromb. Vasc. Bio.
15: 1114-1120
[Abstract][Full Text]
Clark, C. M., Lee, D. A.
(1995). Prevention and Treatment of the Complications of Diabetes Mellitus. NEJM
332: 1210-1217
[Full Text]
Powrie, J K, Watts, G F, Ingham, J N, Taub, N A, Talmud, P J, Shaw, K M
(1994). Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. BMJ
309: 1608-1612
[Abstract][Full Text]
Nathan, D. M.
(1993). Long-Term Complications of Diabetes Mellitus. NEJM
328: 1676-1685
[Full Text]
Sabo, C. E., Michael, S. R.
(1989). Pharmacy Update: Drug Therapy for the Hypertensive Diabetic Patient: Implications for the Diabetes Educator. The Diabetes Educator
15: 377-385
Previous
